Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 16, 2015
Bristol-Myers Squibb Company has announced that the FDA has granted Breakthrough Therapy Designation to Opdivo for the potential indication of advanced or metastatic renal cell carcinoma (RCC).
read more
Wednesday, September 16, 2015
Medivir AB has announced that, as the next step in the company's optimization process, its research and development operations will be merged into a joint unit as of 1 October 2015, headed by Richard Bethell who will hold the new title of EVP ...
read more
Wednesday, September 16, 2015
The ALS Association announced that a critical effort made possible by the ALS Ice Bucket Challenge is underway, involving nearly 100 people with ALS and caregivers, researchers, clinicians, and industry experts from across the country to create drug ...
read more
Thursday, September 17, 2015
Physician-scientist Frank M. Longo, MD, PhD, has been named the inaugural winner of the Alzheimer's Drug Discovery Foundation's (ADDF) Melvin R. Goodes Prize for Excellence in Alzheimer's Drug Discovery, the first prize to specifically recognize ...
read more
Thursday, September 17, 2015
Cumberland Pharmaceuticals, a specialty pharmaceutical company focused on hospital acute care and gastroenterology, has agreed to a strategic alliance with Clinigen Group plc, a global pharmaceutical and services company.
read more
Thursday, September 17, 2015
AbbVie in cooperation with Neurocrine Biosciences, Inc. has announced the completion of a Phase 2b clinical trial evaluating the safety and efficacy of elagolix alone or in combination with add-back therapy compared to placebo
read more
Thursday, September 17, 2015
A newly released study has found that risk-sharing agreements (RSAs) between pharmaceutical companies and health insurers—which could significantly transform the cost and accessibility of medications—are not widely utilized in the U.S. today, but ...
read more
Thursday, September 17, 2015
Impax Laboratories has announced that the FDA has approved generic Mestinon Timespan Tablets (pyridostigmine bromide extended release), 180 mg.
read more
Thursday, September 17, 2015
Amgen and Dezima Pharma B.V. have entered into a definitive acquisition agreement under which Amgen will acquire Dezima, a privately-held, Netherlands-based biotechnology company focused on developing innovative treatments for dyslipidemia.
read more
Friday, September 18, 2015
On September 21, 2015, our group of companies, which presently comprises the trading companies, Huntingdon Life Sciences, Harlan Laboratories, GFA, NDA Analytics, LSR associates and various affiliates will be rebranded as Envigo (pronounced En-vee-go...
read more
Tuesday, September 22, 2015
Xcelience and Powdersize announced today the addition of the Netzsch Delta Vita media mills, a nanoparticle milling solution, to their arsenal of capabilities. For the first time, one CDMO
can provide solutions for a full range of particle size ...
read more
Wednesday, September 23, 2015
Intertek has opened a 10,000 ft² bioanalytical and biopharmaceutical characterization facility to deliver world-class scientific services to support the growing pipeline of biologics medicines such as monoclonal antibodies currently in development by...
read more
Wednesday, September 23, 2015
The FDA has approved trifluridine/tipiracil for the treatment of patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin- , and irinotecan-based chemotherapy, an anti-VEGF biologic product, and ...
read more
Wednesday, September 23, 2015
IDT Biologika has announced the dedication of its first U.S. vaccine manufacturing facility in Rockville, Maryland.
read more
Wednesday, September 23, 2015
Aesica, a global pharmaceutical contract development and manufacturing organization (CDMO), is pleased to announce its involvement in a renewable green initiative involving its UK, Cramlington site.
read more